Logo
x

Search

Subscribe Now

hemophilia a and b

Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B

Novo Nordisk Resumes P-III Study of Concizumab for Patients with Hemophilia A and B

  • August 13, 2020
Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

Novo Nordisk Halts Clinical Studies Evaluating Concizumab (anti-TFPI mAb) for Hemophilia A and B With or Without Inhibitors

  • March 17, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.